Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes

被引：7

作者：

Moya Chimenti, Elisa ^{[1
]}

Herranz de la Morena, Lucrecia ^{[2
]}

Martin Vaquero, Pilar ^{[2
]}

Saez-de-ibarra, Lourdes ^{[2
]}

Garcia Dominguez, Maria ^{[3
]}

Pallardo Sanchez, Luis Felipe ^{[2
]}

机构：

[1] Hosp Infanta Cristina, Dept Endocrinol, Madrid 28981, Spain

[2] La Paz Univ Hosp, Dept Endocrinol, Madrid 28046, Spain

[3] Hosp Sureste, Dept Endocrinol, Madrid 28500, Spain

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2010年 / 90卷 / 03期

关键词：

Continuous subcutaneous insulin infusion (CSII); Diabetes mellitus Type 1 (T1DM); Glycaemic control; PUMP THERAPY; CHILDREN; MELLITUS;

D O I：

10.1016/j.diabres.2010.08.016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We evaluated glycaemic variability with continuous glucose monitoring system in 31 people with Type 1 diabetes mellitus using multiple daily injections initially and after switching to continuous subcutaneous insulin infusion. There was a significant improvement in HbA1c, mean glucose, standard deviation of mean glucose and in hyperglycaemic excursions with CSII. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：E57 / E59

页数：3

共 50 条

[21] Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy
Metzger, Muriel
Lederhendler, Lisa
Corcos, Asher
DIABETES CARE, 2015, 38 (03) : E34 - E35
[22] Glycaemic control in a large cohort of patients with type 1 diabetes treated with continuous subcutaneous insulin infusion
Markakis, K.
Jinadev, P.
Chapman, A.
Urwin, A.
Morris, J.
Boulton, A. J. M.
Rutter, M. K.
Leelarathna, L.
DIABETOLOGIA, 2015, 58 : S442 - S443
[23] Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes
Beato-Vibora, P.
Yeoh, E.
Rogers, H.
Hopkins, D.
Amiel, S. A.
Choudhary, P.
DIABETIC MEDICINE, 2015, 32 (11) : 1453 - 1459
[24] Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes
Beato-Vibora, P.
Yeoh, E. C. K.
Rogers, H.
Hopkins, D.
Amiel, S. A.
Choudhary, P.
DIABETIC MEDICINE, 2015, 32 : 174 - 174
[25] Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability
Pickup, John C.
Kidd, Julia
Burmiston, Sheila
Yemane, Nardos
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (03) : 232 - 237
[26] Assessing glycaemic excursions by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes treated with insulin secretagogues
Li, Y.
Xu, L.
Shen, J.
Ran, J.
Zhang, Y.
Wang, M.
Yan, L.
Fu, Z.
DIABETOLOGIA, 2008, 51 : S13 - S13
[27] Reducing glucose variability with continuous subcutaneous insulin infusion is associated with reversal of axonal dysfunction in type 1 diabetes mellitus
Kamel, Jordan
Loh, Margaret
Cook, Mark
MacIsaac, Richard J.
Roberts, Leslie J.
MUSCLE & NERVE, 2020, 61 (01) : 44 - 51
[28] Continuous Subcutaneous Insulin Infusion (CSII) in Type 2 Diabetes: Reductions in A1C, Mean Glucose, and Variability
Rodbard, David
Anhalt, Henry
Bailey, Timothy
Bode, Bruce
Brunelle, Rocco
Edelman, Steven
Frias, Juan
Kipnes, Mark
DIABETES, 2011, 60 : A252 - A252
[29] Hypoglycemia evaluation using continuous glucose monitoring system in type 1 diabetic patients treated by continuous subcutaneous insulin infusion by pump
Sirault, Bruno
Crenier, Laurent
ACTA CLINICA BELGICA, 2016, 71 : 38 - 38
[30] Continuous Subcutaneous Glucose Monitoring in People with Type 1 Diabetes while Driving a Car
Schmied, Laurent
Zulewski, Henryk
DIABETES, 2015, 64 : A111 - A111

← 1 2 3 4 5 →